Adrenergic and dopaminergic modulation of immunity in multiple sclerosis: teaching old drugs new tricks?
about
Dopamine Receptors and NeurodegenerationSympathoadrenergic modulation of hematopoiesis: a review of available evidence and of therapeutic perspectivesAdrenergic regulation of innate immunity: a reviewVaccination strategies for Parkinson disease: induction of a swift attack or raising tolerance?Immunomodulatory Effects Mediated by DopamineFrom neurons to microglia, with complements.The dopamine imbalance hypothesis of fatigue in multiple sclerosis and other neurological disorders.Cognition and fatigue in patients with relapsing multiple sclerosis treated by subcutaneous interferon β-1a: an observational study SKORERepositioning drugs for inflammatory disease - fishing for new anti-inflammatory agents.Dopaminergic Receptors and Tyrosine Hydroxylase Expression in Peripheral Blood Mononuclear Cells: A Distinct Pattern in Central Obesity.Adrenergic stimulation alters the expression of inflammasome components and interleukins in primary human monocytesTranscription factor Nr4a1 couples sympathetic and inflammatory cues in CNS-recruited macrophages to limit neuroinflammation.Catecholaminergic based therapies for functional recovery after TBIImpaired carotid baroreflex control of arterial blood pressure in multiple sclerosis.Dopaminergic Receptors on CD4+ T Naive and Memory Lymphocytes Correlate with Motor Impairment in Patients with Parkinson's Disease.Dopamine and T cells: dopamine receptors and potent effects on T cells, dopamine production in T cells, and abnormalities in the dopaminergic system in T cells in autoimmune, neurological and psychiatric diseases.Autonomic Nervous System Response to Stressors in Newly Diagnosed Patients with Multiple Sclerosis.Dopamine, T cells and multiple sclerosis (MS).Dopaminergic Regulation of Innate Immunity: a Review.β2 Adrenoceptors are underexpressed in peripheral blood mononuclear cells and associated with a better metabolic profile in central obesity.The Second Insubria Autumn School on Neuroimmune Pharmacology: Repurposing Established Drugs for Novel Indications.cAMP levels in lymphocytes and CD4+ regulatory T-cell functions are affected by dopamine receptor gene polymorphisms.CXCR4 and NMDA Receptors Are Functionally Coupled in Rat Hippocampal Noradrenergic and Glutamatergic Nerve Endings.Expression of dopaminergic receptors on human CD4+ T lymphocytes: flow cytometric analysis of naive and memory subsets and relevance for the neuroimmunology of neurodegenerative disease.Dopaminergic Stimulation of Myeloid Antigen-Presenting Cells Attenuates Signal Transducer and Activator of Transcription 3-Activation Favouring the Development of Experimental Autoimmune Encephalomyelitis.Multiple sclerosis: Repurposing dopaminergic drugs for MS--the evidence mounts.Increased expression of dopamine receptors in synovial fibroblasts from patients with rheumatoid arthritis: inhibitory effects of dopamine on interleukin-8 and interleukin-6.
P2860
Q26783348-09BE31E6-9078-4D0C-95EE-BAF015C8B6B9Q26795526-FD1A71F4-B787-4A9D-BD38-E2EE20446AE5Q26796227-B0CFFC0C-F956-41B3-BA03-BBB5AB39EB75Q27015811-B3325983-3ED7-4ED8-B9C1-D7B33D24695DQ28071580-A34EA1A7-242C-4FA0-B5A0-DB66CCAB764FQ30457175-2A36D4E3-FADC-4683-A44C-38F432BB8208Q30917626-2559DE68-99C0-41CB-99AB-6B641D5449E1Q33589940-067B636B-B9CD-4A1A-818F-AC6E46A20296Q34081764-7CBF8155-947D-423E-BB6C-13EF544D997FQ35903660-8CD27883-129F-4989-9E53-B428E7A063FEQ36502879-64F53779-55B7-4289-AA8D-080B09E84639Q36801851-6C54D59D-3905-4966-9873-F06877A20656Q36909436-EEE4D233-3E8E-46A0-8DF4-3C48632E19F1Q37127749-24DEC2E2-B80E-4A14-941B-043C3FEF704BQ37274056-075B02F7-FA90-4CF7-A887-7A51D7CFBDEFQ38366498-34857614-9C16-48FB-82E2-67163A55FE7AQ38714586-1E2719FC-2687-476A-B0AA-450FB9803FB4Q39173551-68C73D89-D8FD-4162-BB05-A8CA07D86E12Q39348712-D1CB9C7B-9B14-4477-A783-1823557F728AQ41455286-84643AA6-121E-4A9F-A4F5-E6387C94A87FQ47940102-991AFA44-FCB1-47EA-8216-CB68F10667CDQ48305287-F93EB17E-9D60-4F8C-BB54-C98AC3B67B31Q48768162-2EB9EA40-2805-4BBE-A874-43335BB13576Q50855241-15A8FEE8-2F74-4C7D-A549-81745B3ADBC2Q52606148-04BB7ED1-44A5-41B4-AC2A-5F64F5C7271CQ54136860-38F1AA42-625A-427E-AFF7-577BA1838F68Q54200801-512993AC-9A47-42E2-A78E-376E8EFA55EC
P2860
Adrenergic and dopaminergic modulation of immunity in multiple sclerosis: teaching old drugs new tricks?
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Adrenergic and dopaminergic mo ...... teaching old drugs new tricks?
@en
type
label
Adrenergic and dopaminergic mo ...... teaching old drugs new tricks?
@en
prefLabel
Adrenergic and dopaminergic mo ...... teaching old drugs new tricks?
@en
P2860
P1476
Adrenergic and dopaminergic mo ...... teaching old drugs new tricks?
@en
P2093
Franca Marino
P2860
P2888
P304
P356
10.1007/S11481-012-9410-Z
P577
2012-10-17T00:00:00Z
P5875
P6179
1008577582